|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

-
ugi
2,*,
*
Laboratory of T Cell Development, Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021; and
Weill Graduate School of Medical Sciences of Cornell University, New York, NY 10021
The Ig superfamily members TCR and B cell receptor (BCR) share high
structural and amino acid homology, yet interact with Ags in a distinct
manner. The overall shape of the TCR ligand is rather constant, with
the variation coming from the MHC polymorphism and the peptide
heterogeneity. Consequently, the TCR
- and ß-chains form a
relatively flat ligand-binding site that interacts with the peptide:MHC
(pep:MHC) ligand in a fixed diagonal orientation relative to the MHC
-helices, with the
- and ß-chains of the TCR contacting the N
and C termini of the pep:MHC complex, respectively. By contrast, the
shape of BCR ligands varies dramatically, and the BCR exhibits much
greater variability of the Ag-binding site. The mAbs 25-D1.16 (D1) and
22-C5.9 (C5), specific for the OVA-8:H-2Kb complex, allowed
us to directly compare how TCR and BCR approach the same ligand. To
that effect, we mapped D1 and C5 footprints over the
OVA-8:H-2Kb complex. Using peptide variants and mutant MHC
molecules, we show that the D1 and C5 contacts with the
OVA-8:Kb complex C terminus overlap with the TCR ß-chain
footprint, but that this footprint also extends to the regions of the
molecule not contacted by the TCR. These studies suggest that D1 and C5
exhibit a hybrid mode of pep:MHC recognition, in part similar to that
of the TCR ß-chain and in part similar to the conventional
anti-MHC Ab.
This article has been cited by other articles:
![]() |
L. A. Benoit and R. Tan Xenogeneic beta2-Microglobulin Substitution Affects Functional Binding of MHC Class I Molecules by CD8+ T Cells J. Immunol., September 15, 2007; 179(6): 3588 - 3595. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Truscott, L. Lybarger, J. M. Martinko, V. E. Mitaksov, D. M. Kranz, J. M. Connolly, D. H. Fremont, and T. H. Hansen Disulfide Bond Engineering to Trap Peptides in the MHC Class I Binding Groove J. Immunol., May 15, 2007; 178(10): 6280 - 6289. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Racape, F. Connan, J. Hoebeke, J. Choppin, and J.-G. Guillet Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation PNAS, November 28, 2006; 103(48): 18208 - 18213. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mulder, C. Eijsink, M. G. D. Kester, M. E. I. Franke, M. J. Kardol, M. H. M. Heemskerk, C. van Kooten, F. A. Verreck, J. W. Drijfhout, F. Koning, et al. Impact of Peptides on the Recognition of HLA Class I Molecules by Human HLA Antibodies J. Immunol., November 1, 2005; 175(9): 5950 - 5957. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hulsmeyer, P. Chames, R. C. Hillig, R. L. Stanfield, G. Held, P. G. Coulie, C. Alings, G. Wille, W. Saenger, B. Uchanska-Ziegler, et al. A Major Histocompatibility Complex{middle dot}Peptide-restricted Antibody and T Cell Receptor Molecules Recognize Their Target by Distinct Binding Modes: CRYSTAL STRUCTURE OF HUMAN LEUKOCYTE ANTIGEN (HLA)-A1{middle dot}MAGE-A1 IN COMPLEX WITH FAB-HYB3 J. Biol. Chem., January 28, 2005; 280(4): 2972 - 2980. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Laugel, J. M. Boulter, N. Lissin, A. Vuidepot, Y. Li, E. Gostick, L. E. Crotty, D. C. Douek, J. Hemelaar, D. A. Price, et al. Design of Soluble Recombinant T Cell Receptors for Antigen Targeting and T Cell Inhibition J. Biol. Chem., January 21, 2005; 280(3): 1882 - 1892. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Miley, I. Messaoudi, B. M. Metzner, Y. Wu, J. Nikolich-Zugich, and D. H. Fremont Structural Basis for the Restoration of TCR Recognition of an MHC Allelic Variant by Peptide Secondary Anchor Substitution J. Exp. Med., December 6, 2004; 200(11): 1445 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Biddison, R. V. Turner, S. J. Gagnon, A. Lev, C. J. Cohen, and Y. Reiter Tax and M1 Peptide/HLA-A2-Specific Fabs and T Cell Receptors Recognize Nonidentical Structural Features on Peptide/HLA-A2 Complexes J. Immunol., September 15, 2003; 171(6): 3064 - 3074. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lybarger, Y. Y. L. Yu, M. J. Miley, D. H. Fremont, N. Myers, T. Primeau, S. M. Truscott, J. M. Connolly, and T. H. Hansen Enhanced Immune Presentation of a Single-chain Major Histocompatibility Complex Class I Molecule Engineered to Optimize Linkage of a C-terminally Extended Peptide J. Biol. Chem., July 11, 2003; 278(29): 27105 - 27111. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Jankovic, K. Remus, A. Molano, and J. Nikolich-Zugich T Cell Recognition of an Engineered MHC Class I Molecule: Implications for Peptide-Independent Alloreactivity J. Immunol., August 15, 2002; 169(4): 1887 - 1892. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Y. L. Yu, N. Netuschil, L. Lybarger, J. M. Connolly, and T. H. Hansen Cutting Edge: Single-Chain Trimers of MHC Class I Molecules Form Stable Structures That Potently Stimulate Antigen-Specific T Cells and B Cells J. Immunol., April 1, 2002; 168(7): 3145 - 3149. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Messaoudi, J. LeMaoult, B. M. Metzner, M. J. Miley, D. H. Fremont, and J. Nikolich-Zugich Functional Evidence That Conserved TCR CDR{{alpha}}3 Loop Docking Governs the Cross-Recognition of Closely Related Peptide:Class I Complexes J. Immunol., July 15, 2001; 167(2): 836 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Polakova, D. Plaksin, D. H. Chung, I. M. Belyakov, J. A. Berzofsky, and D. H. Margulies Antibodies Directed Against the MHC-I Molecule H-2Dd Complexed with an Antigenic Peptide: Similarities to a T Cell Receptor with the Same Specificity J. Immunol., November 15, 2000; 165(10): 5703 - 5712. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. U.Y. Lee, H. R.O. Churchill, M. Daniels, S. C. Jameson, and D. M. Kranz Role of 2C T Cell Receptor Residues in the Binding of Self- and Allo-Major Histocompatibility Complexes J. Exp. Med., April 18, 2000; 191(8): 1355 - 1364. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |